¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immune state"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • refractory state
    ºÒÀÀ»óÅÂ
  • solid state electrode
    °íüÀü±Ø
  • state
    »óÅÂ
  • state medicine
    »çȸÁÖÀÇÀÇ·á
  • steady state
    Ç×Á¤»óÅÂ, Á¤»ó»óÅÂ
  • steady state coherent sequence
    Ç×Á¤»óŰáÁý¿¬¼â
  • steady-state level
    Ç×Á¤»óżöÁØ
  • vegetative state
    ½Ä¹°»óÅÂ
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • circulating immune complex
    ¼øÈ¯¸é¿ªº¹ÇÕü
  • drug-induced immune complex
    ¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
  • human rabies immune globulin
    »ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°, »ç¶÷±¤°ßº´¸é¿ª±Û·ÎºÒ¸°
  • immune
    ¸é¿ª-
  • immune adherence
    ¸é¿ªºÎÂø
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immune reaction
    ¸é¿ª¹ÝÀÀ
  • immune reactivity
    ¸é¿ª¹ÝÀÀ¼º
  • immune response
    ¸é¿ª¹ÝÀÀ
  • immune selection
    ¸é¿ª¼±ÅÃ
  • immune serum
    ¸é¿ªÇ÷û
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immune system
    ¸é¿ªÃ¼°è
  • immune thrombocytopenia
    ¸é¿ªÀúÇ÷¼ÒÆÇÁõ
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • immune amnesia syndrome
    ¸é¿ª±â¾ï»ó½ÇÁõÈıº
  • immune complex urticaria
    ¸é¿ªº¹Çյε巯±â
  • immune globulin serum
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦
  • immune-mediated urticaria
    ¸é¿ª¸Å°³µÎµå·¯±â
  • memory immune response
    ¸é¿ª±â¾ï¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plastic state
    Çü¼º»óÅÂ(û¡à÷ßÒ÷¾).
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
  • postprandial state
    ½ÄÈÄ »óÅÂ
  • preneoplastic state
    Àü¾Ï»óÅÂ(îñäßßÒ÷¾)
  • proliferative state
    Áõ½Ä»óÅÂ
  • reactive nervous state
    ¹ÝÀÀ¼º ½Å°æ°ú¹Î»óÅÂ(ÚãëëàõãêÌèΦÚÂßÒ÷¾).
  • refractory state
    ºÒÀÀ»óÅÂ, ¹«¹ÝÀÀ»óÅÂ
  • relaxation state
    ÀÌ¿Ï »óÅÂ
  • Acquiered immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌÁõÈıº
  • Immune complex
    ¸é¿ªº¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • Immune system
    ¸é¿ªÃ¼°è(Øóæ¹ô÷ͧ)
  • Rh immune globulin
    Rh ¸é¿ª±Û·Îºí¸°
  • acquired immune deficiency
    ÈÄõ¼º ¸é¿ª°áÇÌ
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immune amnesia syndrome
    ¸é¿ª ±â¾ï»ó½Ç ÁõÈıº
  • immune bacteriolysis
    ¸é¿ª¿ë±Õ.
  • immune cause (hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
  • immune clearance
    ¸é¿ªÅ¬¸®¾î·±½º.
  • immune clearance
    ¸é¿ªÅ¬¸®¾î·±½º.
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune complex
    ¸é¿ªº¹ÇÕü.
  • immune complex disease
    ¸é¿ªº¹ÇÕüº´.
  • immune complex measurement
    ¸é¿ªº¹ÇÕÃ¼ÃøÁ¤
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³ °ú¹Î¹ÝÀÀ
  • immune complex urticaria
    ¸é¿ªº¹Çյε巯±â
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕüÇ÷°ü¿°
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕü¼º Ç÷°ü¿°(Øóæ¹ÜÜùêô÷àõ úìηæú)
  • immune complex-mediated
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹ÎÁõ(Øóæ¹ÜÜùêô÷ØÚ˿ΦÚÂñø)
  • immune complexes
    ¸é¿ªº¹ÇÕü(Øóæ¹ÜÜùêô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • heteroploid state
    À̼ö »óÅÂ(ì¶â¦ßÒ÷¾)
  • hyperploid state
    °ú¹è¼ö »óÅÂ(ΦÛÃâ¦ßÒ÷¾)
  • hypoploid state
    Àú¹è¼ö »óÅÂ(î¸ÛÃâ¦ßÒ÷¾)
  • metastable state
    ÁؾÈÁ¤ »óÅÂ(ñ×äÌïÒßÒ÷¾)
  • oxidation state
    »êÈ­»óÅÂ(ß«ûùßÒ÷¾)
  • polyploid state
    ´Ù¹èü»óÅÂ(ÒýÛÃô÷ßÒ÷¾)
  • postabsorptive state
    Èí¼öÈÄ »óÅÂ(ýåâ¥ý­ßÒ÷¾)
  • pre-steady-state kinetics
    ÀüÁ¤À¯»óÅÂ(îñïÒë§ßÒ÷¾) ¿ªÇÐ(ÕôùÊ)
  • singlet state
    ´ÜÇ×»óÅÂ(Ó¤ú£ßÒ÷¾)
  • standard state
    Ç¥ÁØ »óÅÂ(øöñÞßÒ÷¾)
  • state function
    »óÅ ÇÔ¼ö(ßÒ÷¾ùÞâ¦)
  • state of a system
    ½Ã½ºÅÛ »óÅÂ(ßÒ÷¾)
  • stationary state
    Á¤Áö »óÅ (ïÎò­ßÒ÷¾)
  • stationary-state approximation
    Á¤Áö »óÅÂ(ïÎò­ßÒ÷¾) ¾î¸²¼À
  • steady state
    Á¤·ù »óÅÂ(ïÒ׺ßÒ÷¾)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TIG: (human) Tetanus Immune(Immuno-) Globulin ÆÄ»ódz Àΰ£ ¸é¿ª ±Û·ÎºÒ¸°
AIDS acquired immune deficiency syndrome
AIDS-KS acquired immune deficiency syndrome with Kaposi's sarcoma
AIHD acquired immune hemolytic disease
CIC cardioinhibitor center; circulating immune complex; clean intermittent catheterization; completely i...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MMS Mini Mental State Examination
MMSE Mini Mental State Examination
3MS Mini-Mental State
NYS New York State
OSU Ohio State University
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • excitation state
    ¿©±â »óÅÂ, ÈïºÐ »óÅÂ
  • fast imaging with steady state precession
    Ç×Á¤ »óÅ ¼¼Â÷ ¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó ¿µ»ó
  • fear state
    °øÆ÷ »óÅÂ
  • Fourier acquisition in the steady state sequence
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • hyperergic state
    Ç׿ø °ú¹Î »óÅÂ
  • hypoglycemic state
    ÀúÇ÷´ç¼º »óÅÂ
  • immunological deficiency state
    ¸é¿ª °áÇÌ »óÅÂ
  • index of occlusal state
    ±³ÇÕ »óÅ Áö¼ö
  • lacunar state
    ¿­°ø »óÅÂ
  • latent state
    ÀáÀç »óÅÂ
    Àẹ±âÀÇ ±ÕÀÇ »óÅÂ. ±Õ ÀÚ½ÅÀÇ º´Àû Ư¼ºÀ» ¹ßÈÖÇÏÁö ¸øÇϰí ÀÖ´Â »óÅÂ.
  • open state
    °³¹æ »óÅÂ
  • ordinary state
    »óÅÂ
  • paranoid state
    ÆíÁý »óÅÂ
  • partial saturation state
    ºÎºÐ Æ÷È­ »óÅÂ
  • persistent vegetative state
    Áö¼ÓÀû ½Ä¹° »óÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
state health plans State plans prepared by the state health planning and development agencies which are made up from plans submitted by the health systems agencies and subject to review and revision by the statewide health coordinating council.
(12 Dec 1998)
state hospital A hospital supported in part by taxpayers and administered by state government officials.
(05 Mar 2000)
state implementation plan A state plan required by the Clean Air act to bring nonattainment areas into compliance with federal ambient air quality standards.
(05 Dec 1998)
state medicine A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.
(12 Dec 1998)
steady state A dynamic equilibrium.
(13 Nov 1997)
steady-state rate The velocity of an enzyme-catalyzed reaction in which, over the time course of the study, the concentration of any enzyme species is constant (i.e., for an enzyme-substrate binary complex, ES, d[ES]/dt&apprxeq;00; for this to hold true, the total enzyme concentration must be much less than the initial substrate concentration.
Synonym: steady-state rate.
(05 Mar 2000)
steady-state velocity The velocity of an enzyme-catalyzed reaction in which, over the time course of the study, the concentration of any enzyme species is constant (i.e., for an enzyme-substrate binary complex, ES, d[ES]/dt&apprxeq;00; for this to hold true, the total enzyme concentration must be much less than the initial substrate concentration.
Synonym: steady-state rate.
(05 Mar 2000)
decerebrate state A peculiar neurologic condition elicited in vertebrates as a consequence of the elimination of brain function by transecting the brainstem or interrupting function by other techniques. Clinically, brain damage can result in neurological signs resembling those of a decerebrate animal. The state consists of exaggerated postures, grossly abnormal reflexes, convulsions, and extreme muscular rigidity and spasticity.
(12 Dec 1998)
decorticate state A unilateral or bilateral postural change, consisting of the upper extremities flexed and adducted and the lower extremities in rigid extension; due to structural lesions of the thalamus, internal capsule, or cerebral white matter.
Synonym: decorticate state.
(05 Mar 2000)
dreamy state The saemiconscious state associated with an epileptic attack.
Synonym: absent state.
(05 Mar 2000)
imperfect state In fungi, the state or stage at which only asexual spores such as conidia are formed; most such species are classified as Deuteromycetes (Fungi Imperfecti).
(05 Mar 2000)
transition state The activated state of a molecule that has partly undergone a chemicalreaction.
(09 Oct 1997)
transition state intermediate In a chemical reaction, an unstable and high-energy configuration assumed by reactants on the way to making products. Enzymes are thought to bindand stabilise the transition state, thus lowering the energy of activation needed to drive the reaction to completion.
(09 Oct 1997)
triplet state A second excited state of a molecule (e.g., chlorophyll) produced by absorption of light to produce the singlet state, then loss of some energy (fluorescence) to arrive at the longer-lived triplet state The molecule may remain sufficiently long in the triplet state for a second activating light quantum to be effective in producing a "second triplet" state, obviously at still a higher level of excitation, hence reactivity. Alternatively, it may lose the triplet state energy directly and return to the ground state.
(05 Mar 2000)
eunuchoid state An imprecisely delineated condition of a male manifesting signs of inadequate androgen secretion during adolescent growth, regardless of the cause; usually referring to long legs, short trunk, and boyish beardless faces.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Flickertail State
    ¹Ì±¹ North DakotaÁÖÀÇ ¼ÓĪ
  • Flower State
    ¹Ì±¹ FloridaÁÖÀÇ ¼ÓĪ
  • Free State
    ÀÚÀ¯ÁÖ
  • Gem State
    ¹Ì±¹ IdahoÁÖÀÇ ¼ÓĪ
  • Golden State
    ¹Ì±¹ CaliforniaÁÖÀÇ ¼ÓĪ
  • Gopher State
    x;¹Ì±¹ Minnesota wndml thrcld
  • Grand Canyon State
    ¹Ì±¹ ArizoaÁÖÀÇ ¼ÓĪ
  • Granite State
    ¹Ì±¹ New HampshireÁÖÀÇ ¼ÓĪ
  • Green Mountain State
    vermont ÁÖÀÇ ¼ÓĪ
  • Hawkeyed State
    IowaÁÖÀÇ µý À̸§
  • Hoosier State
    IndianaÁÖÀÇ ¼ÓĪ
  • Irish Free State
    ¾ÆÀÏ·£µå ÀÚÀ¯±¹)
  • Keystone state
    Ææ½Çº£À̴ϾÆÁÖÀÇ µý À̸§
  • Lake State
    ¹Ì±¹ÁÖÀǺ°Äª
  • Magnolia State
    Mississippi ÁÖÀÇ ¼ÓĪ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á